Stéphane Oudard

ScholarGPS® ID: 34793079160153

Highly Ranked Scholar - Lifetime:

Docetaxel

#30

Renal cell carcinoma

Show Less

Affiliation

Université de Paris, Paris, France

Affiliation History

Field

Medicine

Discipline

Oncology

Top Specialties

Metrics Summary

Publication Count

744

Predicted Citations

65,901

Predicted h-index

102

Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
Characterization of Responses to Lenvatinib plus Pembrolizumab in Patients with Advanced Renal Cell Carcinoma at the Final Prespecified Survival Analysis of the Phase 3 CLEAR Study (journal article) Motzer, Robert J. \| Choueiri, Toni K. \| Hutson, Thomas \| Young Rha, Sun \| Puente, Javier \| Lalani, Aly-Khan A. \| Winquist, Eric \| Eto, Masatoshi \| Basappa, Naveen S. \| Tannir, Nizar M. \| ... \| Powles, Thomas European Urology, volume 86, issue 1, pages 4-9 (2024). 10.1016/j.eururo.2024.03.015 Cite \| Source
A Signal-Finding Study of Abemaciclib in Heavily Pretreated Patients with Metastatic Castration–Resistant Prostate Cancer: Results from CYCLONE 1 (journal article) Agarwal, Neeraj \| Castellano, Daniel \| Alonso-Gordoa, Teresa \| Arranz Arija, Jose Angel \| Colomba, Emeline \| Gravis, Gwenaelle \| Mourey, Loic \| Oudard, Stephane \| Fléchon, Aude \| González, Macarena \| ... \| Piulats, José M. Clinical Cancer Research, volume 30, issue 11, pages 2377-2383 (2024). 10.1158/1078-0432.CCR-23-3436 Cite \| Source
Phase Ib INEOV neoadjuvant trial of durvalumab +/- tremelimumab with platinum chemotherapy for patients (pts) with unresectable ovarian cancer (OC): Survival outcomes and immune correlates. (journal article) Leary, Alexandra \| Chardin, Laure \| Lortholary, Alain \| Asselain, Bernard \| Alexandre, Jerome \| Lebreton, Coriolan \| Savoye, Aude-Marie \| Oudard, Stephane \| Gavoille, Céline \| You, Benoit \| ... \| Pujade-Lauraine, Eric Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 5569-5569 (2024). 10.1200/JCO.2024.42.16_suppl.5569 Cite \| Source
Adverse myocardial and vascular side effects of immune checkpoint inhibitors: a prospective multimodal cardiovascular assessment (journal article) Mirabel, Mariana \| Eslami, Assié \| Thibault, Constance \| Oudard, Stéphane \| Mousseaux, Elie \| Wahbi, Karim \| Fabre, Elizabeth \| Terrier, Benjamin \| Marijon, Eloi \| Villefaillot, Aurélie \| ... \| Hulot, Jean Sébastien Clinical Research in Cardiology (2024). 10.1007/s00392-024-02462-x Cited by (2) \| Cite \| Source
Belzutifan for von Hippel–Lindau Disease: Pancreatic Lesion Population of the Phase 2 LITESPARK-004 Study (journal article) Else, Tobias \| Jonasch, Eric \| Iliopoulos, Othon \| Beckermann, Kathryn E. \| Narayan, Vivek \| Maughan, Benjamin L. \| Oudard, Stephane \| Maranchie, Jodi K. \| Iversen, Ane B. \| Goldberg, Cynthia M. \| ... \| Srinivasan, Ramaprasad Clinical Cancer Research, volume 30, issue 9, pages 1750-1757 (2024). 10.1158/1078-0432.CCR-23-2592 Cite \| Source
Prognostic Value of the Modeled Prostate-Specific Antigen KELIM Confirmation in Metastatic Castration-Resistant Prostate Cancer Treated With Taxanes in FIRSTANA (journal article) Carrot, Aurore \| Oudard, Stéphane \| Colomban, Olivier \| Fizazi, Karim \| Maillet, Denis \| Sartor, Oliver \| Freyer, Gilles \| You, Benoit JCO Clinical Cancer Informatics (2024). 10.1200/CCI.23.00208 Cite \| Source
Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carcinoma (journal article) Powles, Thomas \| Assaf, Zoe June \| Degaonkar, Viraj \| Grivas, Petros \| Hussain, Maha \| Oudard, Stephane \| Gschwend, Jürgen E. \| Albers, Peter \| Castellano, Daniel \| Nishiyama, Hiroyuki \| ... \| Mariathasan, Sanjeev European Urology, volume 85, issue 2, pages 114-122 (2024). 10.1016/j.eururo.2023.06.007 Cited by (12) \| Cite \| Source
Nivolumab immunotherapy rechallenge for progressive laryngeal squamous cell carcinoma after failure of conventional treatment: A CARE case report (journal article) Gervais, C. \| Auclin, E. \| Saltel-Fulero, A. \| Clair, G. \| Oudard, S. \| Mirghani, H. European Annals of Otorhinolaryngology, Head and Neck Diseases (2024). 10.1016/j.anorl.2024.02.003 Cite \| Source
Effect of erythropoietin-stimulating agent use on belzutifan antitumor activity in patients with VHL disease–associated renal cell carcinoma: Post hoc analysis of the LITESPARK-004 study. (journal article) Maughan, Benjamin L. \| Srinivasan, Ramaprasad \| Iliopoulos, Othon \| Bundsbæk Bøndergaard Iversen, Ane \| Narayan, Vivek \| Oudard, Stephane \| Else, Tobias \| Maranchie, Jodi K. \| Beckermann, Katy \| Fu, Wei \| ... \| Jonasch, Eric Journal of Clinical Oncology, volume 42, issue 4_suppl, pages 3-3 (2024). 10.1200/JCO.2024.42.4_suppl.3 Cite \| Source
Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN (journal article) Shen, John \| Chowdhury, Simon \| Agarwal, Neeraj \| Karsh, Lawrence I. \| Oudard, Stéphane \| Gartrell, Benjamin A. \| Feyerabend, Susan \| Saad, Fred \| Pieczonka, Christopher M. \| Chi, Kim N. \| ... \| Graff, Julie N. British Journal of Cancer, volume 130, issue 1, pages 73-81 (2024). 10.1038/s41416-023-02492-8 Cited by (2) \| Cite \| Source
Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs) (journal article) Daban, A \| Gonnin, C \| Phan, L \| Saldmann, A \| Granier, C \| Lillo-Lelouet, A \| Le Beller, C \| Pouchot, J \| Weiss, l \| Tartour, E \| ... \| Simonaggio, A. OncoImmunology, volume 12, issue 1 (2023). 10.1080/2162402X.2023.2204754 Cited by (7) \| Cite \| Source
Post Hoc Analysis of Rapid and Deep Prostate-specific Antigen Decline and Patient-reported Health-related Quality of Life in SPARTAN and TITAN Patients with Advanced Prostate Cancer (journal article) Small, Eric J. \| Chi, Kim N. \| Chowdhury, Simon \| Bevans, Katherine B. \| Bhaumik, Amitabha \| Saad, Fred \| Chung, Byung Ha \| Karsh, Lawrence I. \| Oudard, Stéphane \| De Porre, Peter \| ... \| Agarwal, Neeraj European Urology Oncology (2023). 10.1016/j.euo.2023.11.015 Cited by (3) \| Cite \| Source
HORM-OS : un parcours de soins pour améliorer le dépistage de l’ostéoporose chez les patients avec un cancer de prostate initiant une hormonothérapie (journal article) Fogel, O. \| Dariane, C. \| Bibault, J.E. \| Kreps, S. \| Thibault, C. \| Gervais, C. \| Meynard, C. \| Rochand, A. \| Rapeaud, E. \| Hmila, S. \| ... \| Briot, K. Revue du Rhumatisme, volume 90 (2023). 10.1016/j.rhum.2023.10.454 Cite \| Source
Impact of First Line Antiangiogenic Therapy Duration on Nivolumab Outcome in Metastatic Renal Cell Carcinoma Patients Treated in the GETUG—AFU 26 NIVOREN (journal article) Guilhem-Ducléon, Guillemette \| Dalban, Cécile \| Negrier, Sylvie \| Gravis, Gwenaelle \| Laguerre, Brigitte \| Chevreau, Christine \| Oudard, Stéphane \| Barthelemy, Philippe \| Ladoire, Sylvain \| Boughalem, Elouen \| ... \| Goupil, Marine Gross Clinical Genitourinary Cancer, volume 21, issue 6, pages 643-652 (2023). 10.1016/j.clgc.2023.07.008 Cite \| Source
CTNI-71. BELZUTIFAN FOR VON HIPPEL-LINDAU DISEASE-RELATED CENTRAL NERVOUS SYSTEM (CNS) HEMANGIOBLASTOMAS: SUBGROUP OF PHASE 2 LITESPARK-004 STUDY (journal article) Iliopoulos, Othon \| Iversen, Ane B \| Narayan, Vivek \| Maughan, Benjamin L \| Beckermann, Kathryn E \| Oudard, Stephane \| Else, Tobias \| Maranchie, Jodi K \| Fu, Wei \| Perini, Rodolfo F \| ... \| Jonasch, Eric Neuro-Oncology, volume 25, issue Supplement_5, pages v93-v93 (2023). 10.1093/neuonc/noad179.0353 Cite \| Source
OA15.05 Lung Immune Prognostic Index Predicts Outcomes from Upfront Chemotherapy + Immunotherapy +/- Antiangiogenic in Advanced NSCLC (journal article) Roulleaux Dugage, M. \| Gorria, T. \| Rochand, A. \| Garcin, L.-M. \| Oudard, S. \| Albarrán-Artahona, V. \| Laguna, J.C. \| Nalda, I. \| Muñoz-Carrillo, F.J. \| Aguilar, L. \| ... \| Auclin, E. Journal of Thoracic Oncology, volume 18, issue 11, pages S80- (2023). 10.1016/j.jtho.2023.09.082 Cite \| Source
1450P Addition of bevacizumab to first-line chemoimmunotherapy in NSCLC with liver metastases (journal article) Roulleaux Dugage, M. \| Tagliamento, M. \| Gorria, T. \| Rochand, A. \| Garcin, L-M. \| Oudard, S. \| Thibault, C. \| Albarran Artahona, V.M. \| Laguna Montes, J.C. \| Nalda Ariza, I. \| ... \| Auclin, E. Annals of Oncology, volume 34 (2023). 10.1016/j.annonc.2023.09.2481 Cite \| Source
1062P Anti-PD1 efficacy in European patients with advanced MSI-H/MMRd non-colorectal cancers (journal article) Tournigand, C. \| Flechon, A. \| Oudard, S. \| Saada, E.B. \| Pouessel, D. \| Le Tourneau, C. \| Augereau, P. \| Beylot-Barry, M. \| Grob, J.J. \| Chibaudel, B. \| ... \| Marabelle, A. Annals of Oncology, volume 34 (2023). 10.1016/j.annonc.2023.09.2201 Cite \| Source
SYST-18 BELZUTIFAN TREATMENT FOR PATIENTS WITH VON HIPPEL-LINDAU DISEASE–ASSOCIATED CENTRAL NERVOUS SYSTEM HEMANGIOBLASTOMAS ENROLLED IN THE PHASE 2 LITESPARK-004 STUDY (journal article) Narayan, Vivek \| Iliopoulos, Othon \| Iversen, Ane B \| Maughan, Benjamin L \| Beckermann, Kathryn E \| Oudard, Stephane \| Else, Tobias \| Maranchie, Jodi K \| Fu, Wei \| Perini, Rodolfo F \| ... \| Jonasch, Eric Neuro-Oncology Advances, volume 5, issue Supplement_3, pages iii31-iii31 (2023). 10.1093/noajnl/vdad070.122 Cite \| Source
POS0502 IMPLEMENTATION OF A CLINICAL CARE PATHWAY FOR SYSTEMATIC BONE FRAGILITY ASSESSMENT AT THE INITIATION OF ANDROGEN DEPRIVATION IN PROSTATE CANCER PATIENTS (HORMOS PROJECT) (conference) Fogel, O. \| Dariane, C. \| Bibault, J. E. \| Kreps, S. \| Thibault, C. \| Gervais, C. \| Rochand, A. \| Meynard, C. \| Rapeaud, E. \| Hmila, S. \| ... \| Briot, K. EULAR 2023 European Congress of Rheumatology, 31 May - 3 June. Milan, Italy (2023) 10.1136/annrheumdis-2023-eular.5760 Cite \| Source